New Approach for Diagnostics of VZV Infection by Using Real-Time PCR

Clinical picture of diseases caused by VZV in immunocompromised patients is often differed from healthy people and has no visible skin damage. Diagnostics in such cases is difficult but it is important to find out real reason of health deterioration for assignment the treatment. That explains usefulness of molecular methods in diagnostics of VZV-infection. So the goal of this study was checking out usefulness of diagnostics based on detection viral DNA in clinical samples by real-time PCR method. We used pools of peripheral blood samples from sick and healthy patients as clinical materials for analysis and Varilrix vaccine sample as a source of positive control viral DNA. Main methods used here were DNA extraction and real-time PCR in the version of TaqMan probes; amplification reactions were made in triplicates for each sample with standard deviation of threshold cycles less than 1.5%. Amplification results of clinical samples from patients were analyzed by comparison with the results from positive control viral DNA. Final resulting figures were slightly varied and dependent on selected for amplification VZV genome fragment (orf 29 or orf 38), and viral DNA had been detected in 48% of sick patients and only in 4% of practically healthy donors without zoster symptoms. Concluding, we approved the possibility of use real-time PCR as a molecular method for laboratory diagnostics VZV-infection including atypical and subclinical disease forms. One of the advantage of the method described is the possibility of DNA detection straight from blood samples (without extra purification steps such as preparation mononuclear cell fraction from blood samples), therefore this approach can accelerate and simplify diagnostic procedure.

Varicella Zoster Virus, VZV-инфекция, ветряная оспа, опоясывающий герпес, вирусная ДНК, ПЦР в режиме реального времени, молекулярная диагностика, Varicella Zoster Virus, VZV-infection, chickenpox, herpes zoster, viral DNA, real-time PCR, molecular diagnostics

1. Reynolds M.A., Kruszon-Moran D., Jumaan A., Schmid D.S., McQuillan G.M. Varicella seroprevalence in the U.S.: data from the National Health and Nutrition Examination Survey, 1999 – 2004. Public Health Rep. 2010, 125 (6): 860 – 869.

2. Lavrov V.F., Kazanova A.S., Kuzin S.N., Dubodelov D.V. Varicella and herpes zoster: morbidity and clinical manifestations. Jepidemiologija i infekcionnye bolezni. Aktual’nye voprosy. [Epidemiol. Infect. Dis. Curr. Items]. Moscow. 2011; 3: 54 – 60 (in Russian).

3. E., Shahzad A., Cohrs R.J. Varicella zoster virus latency. Future Virol. 2011; 6 (3): 341 – 355.

4. Gilden D.H., Gesser R., Smith J., Wellish M., Laquardia J.J., Cohrs R.J., Mahalinqam R. Presence of VZV and HSV-1 DNA in human nodose and celiac ganglia. Virus Genes. 2001, 23 (2): 145 – 147.

5. Kazanova A.S., Lavrov V.F., Zverev V.V. Varicella Zoster virus and diseases of central nervous system vessels. Zhurnal mikrobiologii. [Journal of microbiology]. Moscow. 2015; 3: 106 – 116 (in Russian).

6. Amlie-Lefond C., Jubelt B. Neurologic manifestations of Varicella Zoster virus infections. Curr. Neurol. Neurosci. Rep. 2009; 9 (6): 430 – 434.

7. Gilden D., Cohrs R.J., Mahalingam R., Nagel M.A. Neurological disease produced by varicella zoster virus reactivation without rash. Curr. Top Microbiol. Immunol. 2010, 342: 243 – 253.

8. Gilden D.H., Dueland A.N., Devlin M.E., Mahalingam R., Cohrs R. Varicella-zoster virus reactivation without rash. J. Infect. Dis. 1992; 166 (Suppl. 1): 30 – 34.

9. Kazanova A.S., Lavrov V.F., Kuzin S.N., Ebralidze L.K., Vedunova S.L., Malyshev N.A. et al. Comparative evaluation of effectiveness of traditional serologic and modified methods of herpes zoster laboratory diagnostics. Zhurnal mikrobiologii [Journal of microbiology]. Moscow. 2013; 2: 83 – 90 (in Russian).

10. Fam H.Ph., Borovikova E.A., Sidorov A.V., Karataeva A.V., Antonova T.P., Zverev V.V. Possibility of using nested polymerase chain reaction for diagnostics of diseases caused by Varicella Zoster Virus. Zhurnal mikrobiologii [Journal of microbiology]. Moscow. 2015, 3: 25 – 30 (in Russian).

11. Maniatis, T., Fritsch, E., J. Sambrook. Methods of genetic engineering. Molecular cloning. Moscow: Mir. 1984: 402 – 407.

12. Alatortseva G.I., Sidorov A.V., Nesterenko L.N., Luhverchik L.N., Amiantova I.I., Docenko V.V. et al. Recombinant Analogue of Varicella Zoster Virus Glycoprotein E: Cloning, Expression and Studying of Antigen Properties. Zh. Epidemiol. Vac. Prevent. (Moscow). 2016, 15(1): 77-86 (in Russian).

13. Depledge D.P., Palser A.L.,Watson S.J., Yi-Chun LaiI., Gray E.R., Grant P. et al. Specific capture and whole-genome sequencing of viruses from clinical samples. PloS One 2011; 6 (11): e27805.

14. Watzinger F., Suda M., Preuner S., Baumgartiner R., Ebner K., Baskova L. et al. Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients J. Clin. Mircrobiol. 2004, 42 (11): 5189 – 5198.

15. Dean F.B., Hosono S., Fang L., Wu X., Faruqi A.F., Bray-Ward P. et al. Comprehensive Human Genome Amplification Using Multiple Displacement Amplification. Proc. Natl. Acad. Sci. USA. 2002; 99 (8): 5261 – 5266.

16. Tyler S.D., Peters G.A., Grose C., Severini A., Gray M.J., Upton C. et al. Genomic cartography of varicella-zoster virus: a complete genome-based analysis of strain variability with implications for attenuation and phenotypic differences. Virology. 2007, 359: 447 – 458.

17. Loparev V.N., Gonzalez A., Deleon-Carnes M., Tipples G., Fickenscher H., Torfason E.G. et al. Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping. J. Virol. 2004, 78: 8349 – 8358.

18. Ozaki T., Ichikawa T., Matsui Y., Kondo H., Nagai T., Asano Y. et al. Lymphocyte-associated viremia in varicella. J. Med. Virol. 1986; 19: 249 – 253.

19. Asano Y., Itakura N., Kajita Y., Suga S., Yoshikawa T., Yazaki T. et al. Severity of viremia and clinical findings in children with varicella. J. Infect. Dis. 1990, 161 (6): 1095 – 1098.

20. Koropchak C.M., Solem S.M., Diaz P.S., Arvin A.M. Investigation of varicella-zoster virus infection of lymphocytes by in situ hybridization. J. Virol. 1989, 63: 2392-2395.

21. Koropchak C.M., Graham G., Palmer J., Winsberg M., Ting S.F., Wallace M. et al. Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella. J. Infect. Dis. 1991; 163: 1016 – 1022.

22. Kelley R., Mancao M., Lee F., Sawyer M., Nahmias A., Nesheim S. Varicella in children with perinatally acquired human immunodeficiency virus infection. J. Pediatr. 1994; 124 (2): 271 – 273.

23. Schott G.D. Triggering of delayed-onset postherpetic neuralgia. Lancet 1998; 351: 419 – 420.

24. Amlie-Lefond C., Mackin G.A., Ferguson M., Wright R.R., Mahalingam R., Gilden D.H. Another case of virologically confirmed zoster sine herpete, with electrophysiologic correlation. J. Neurovirol. 1996; 2: 136 – 138.